soul trial semaglutide Oral Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the Randomized SELECT Trial

The GLP-1 component handles appetite suppression and insulin regulation, similar to what semaglutide does alone

ME-T: Supervision, Validation, Visualization, Writing review & editing

Manufacturing capacity is catching up to demand, progressively lifting the supply constraints that have prevented GLP-1 prescriptions from being filled at the rate physicians would like to write them

If the drug has NCE exclusivity and the ANDA is submitted four years after approval, the 30-month stay is extended so that it expires seven and a half years after approval of the innovator drug, unless the patent expires or there is a decision in the infringement case that is favorable to the ANDA applicant before then